Natural Killer Cell Subsets Differentially Reject Embryonic Stem Cells Based on Licensing

BACKGROUNDEmbryonic stem cells (ESC) and induced pluripotent stem cells provide great promise to the future of medicine. Because immune rejection represents a major obstacle to the success of all stem cell–based therapies, many recent studies have sought to determine the key immune mediators involve...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transplantation 2014-05, Vol.97 (10), p.992-998
Hauptverfasser:	Perez-Cunningham, Jessica, Ames, Erik, Smith, Rachel C, Peter, Anna K, Naidu, Ridhima, Nolta, Jan A, Murphy, William J
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Cells, Cultured Disease Models, Animal Embryonic Stem Cells - immunology Graft Rejection - immunology Graft Rejection - pathology Humans Immunity, Cellular Killer Cells, Natural - immunology Mice Mice, Inbred C57BL Stem Cell Transplantation Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!